Rijneveld A, van der Holt B, de Weerdt O, et al. Randomized phase III HOVON-100 study of clofarabine combined with standard treatment in adult patients with newly diagnosed ALL. 24th Congress of EHA, abstract PS937.
Fysieke inactiviteit de grootste modificeerbare risicofactor in de geneeskunde
jan 2024 | Leukemie, Lymfoom, MDS, MM, MPN